The path to gout remission: integrating risk awareness, patient collaboration, and targeted therapy (IMAGE)

Chinese Medical Journals Publishing House Co., Ltd.

The path to gout remission: integrating risk awareness, patient collaboration, and targeted therapy

Caption

Prolonged hyperuricemia is a major risk factor for gout, which is now regarded as a curable disease. Awareness of the various factors that can trigger gout flares is essential for their prevention. An important determinant of treatment decisions and long-term follow-up is the quality of the clinician–patient relationship. The "treat-to-target" approach is recommended to support achieving the simplified remission criteria in clinical practice.

Credit

Rheumatology & Autoimmunity

Usage Restrictions

Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.

License

CC BY-NC-ND

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.